SCHEMBL4842885

SCHEMBL4842885

CCNC(=O)c1cccc(C(=O)/C=C2\NC(C)(C)Cc3ccc(OC)cc32)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
KDM4E B2RXH2 1/20 0.46
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 3/20 0.43
GAA P10253 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
HPGD P15428 2/20 0.43
MAPT P10636 3/20 0.41
HTT P42858 1/20 0.41
MMP13 P45452 1/20 0.40
OPRM1 P35372 2/20 0.40
OPRD1 P41143 2/20 0.40
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
NPC1 O15118 1/20 0.39
HCN1 O60741 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4842896 1.00 LMNA (0.46) LMNAKDM4EKMT2AALDH1A1GAA
SCHEMBL4842927 0.92 LMNA (0.48) LMNAKDM4EKMT2AALDH1A1GAA
SCHEMBL4842913 0.92 LMNA (0.48) LMNAKDM4EKMT2AALDH1A1GAA
SCHEMBL4846443 0.91 KMT2A (0.43) LMNAKDM4EKMT2AALDH1A1GAA
SCHEMBL4844302 0.91 ALDH1A1 (0.44) LMNAKDM4EKMT2AALDH1A1GAA
SCHEMBL4839523 0.91 PKM (0.46) LMNAKDM4EKMT2AALDH1A1GAA
SCHEMBL4844279 0.91 ALDH1A1 (0.44) LMNAKDM4EKMT2AALDH1A1GAA
SCHEMBL4839515 0.91 PKM (0.46) LMNAKDM4EKMT2AALDH1A1GAA
SCHEMBL4846453 0.91 KMT2A (0.43) LMNAKDM4EKMT2AALDH1A1GAA
SCHEMBL4843490 0.90 KMT2A (0.42) LMNAKDM4EKMT2AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US claimed
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 LMNA 3014/4885KDM4E 4466/4885KMT2A 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.